Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the phenylpiperidine class. It features a piperidinone core substituted with both chlorinated and fluorinated aromatic rings and a dithiolane moiety. The structure is closely related to haloperidol derivatives and is sometimes referred to as "thioketal haloperidol." It has been cataloged in chemical databases (DrugBank DB08622; PDB code THK) but does not have an established clinical use or approved indication. Its mechanism of action has not been characterized in the literature or major drug databases, and it appears primarily as an experimental or research compound[1][6][9]. No information on pharmacological activity, primary indication, or developer is available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-(4-chlorophenyl)-1-{3-[2-(4-fluorophenyl)-1,3-dithiolan-2-yl]propyl}piperidin-4-ol.